Previous Close | 48.12 |
Open | 47.75 |
Bid | 0.00 x 1100 |
Ask | 0.00 x 800 |
Day's Range | 46.35 - 47.94 |
52 Week Range | 35.17 - 60.47 |
Volume | |
Avg. Volume | 908,755 |
Market Cap | 2.425B |
Beta (5Y Monthly) | 1.09 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.72 |
Earnings Date | Feb 21, 2023 - Feb 27, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 55.38 |
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its fourth quarter and full-year 2022 results on Wednesday, February 22, 2023, after the close of the market.
NuVasive, Inc. ( NASDAQ:NUVA ) shareholders should be happy to see the share price up 10% in the last quarter. But that...
NuVasive (NUVA) believes that its 2022 guidance is appropriately conservative, considering macroeconomic pressures on net sales and operating profit.